Ho Chanda K, Asrani Sumeet K
Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.
Baylor University Medical Center, Baylor Scott and White, Dallas, TX, United States.
J Clin Exp Hepatol. 2025 Nov-Dec;15(6):102628. doi: 10.1016/j.jceh.2025.102628. Epub 2025 Jun 21.
Artificial intelligence (AI) is fundamentally changing how modern medicine is practiced with the intent of advancing and accelerating patient care and improving both patient experience and outcomes. AI, however, has been confronted by several challenges, including but not limited to ethics, regulation, and public trust. This paper explores an approach to AI governance in healthcare, specifically in hepatology. As AI continues to grow, it will be crucial for healthcare providers and our community as hepatologists to understand the implications and impact of this growth and what this means for our practice and patients. We draw from existing AI frameworks, principles of medical ethics, as well as quality healthcare principles to propose our framework for AI in hepatology. Our proposed framework includes patient-centered care, non-maleficence and safety, equity, transparency, accountability, and security and privacy. For each of these topics, we discuss examples relevant to hepatology. We also propose an action plan for hepatologists on how each of these principles can be upheld in our day-to-day practice. While many hepatology specific AI applications are currently being tested in research studies, they have not yet made it to "prime time." As a result, the hepatology community has time to consider governance structures to put in place in preparation for the inherent challenges that come with AI implementation and integration into clinical care to ensure that care is responsible, ethical, safe, and secure. With careful and conscientious planning, the inclusion of relevant stakeholders, and laying the groundwork for governance, AI can improve quality of health care in hepatology with efficiency, improved safety, and equity.
人工智能(AI)正在从根本上改变现代医学的实践方式,旨在推进和加速患者护理,并改善患者体验和治疗结果。然而,人工智能面临着若干挑战,包括但不限于伦理、监管和公众信任。本文探讨了医疗保健领域,特别是肝病学领域的人工智能治理方法。随着人工智能的不断发展,对于医疗保健提供者以及我们肝病学领域的同行来说,理解这种发展的影响和意义以及这对我们的实践和患者意味着什么至关重要。我们借鉴现有的人工智能框架、医学伦理原则以及优质医疗保健原则,提出我们的肝病学人工智能框架。我们提出的框架包括以患者为中心的护理、无害和安全、公平、透明、问责以及安全和隐私。对于这些主题中的每一个,我们都讨论了与肝病学相关的示例。我们还为肝病学家提出了一项行动计划,说明如何在日常实践中坚持这些原则。虽然目前许多针对肝病学的人工智能应用正在研究中进行测试,但它们尚未进入“黄金时期”。因此,肝病学界有时间考虑建立治理结构,为人工智能实施和融入临床护理所带来的固有挑战做好准备,以确保护理是负责任的、符合伦理的、安全的和有保障的。通过精心和认真的规划、纳入相关利益攸关方以及为治理奠定基础,人工智能可以提高肝病学医疗保健的质量,实现高效、提高安全性和公平性。